Clinical Trial Update: A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating guselkumab in moderately to severely active ulcerative colitis across Phase 2 and Phase 3 is ongoing with results posted and status not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Ulcerative Colitis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-11-18